PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta(R)): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers

Moosavi, S; Borema, T; Ewesuedo, R; Harris, S; Levy, J; May, TB; Summers, M; Thomas, JS; Zhang, J; Yao, HM

Yao, HM (corresponding author), Pfizer Inc, Lake Forest, IL 60045 USA.

ADVANCES IN THERAPY, 2020; 37 (7): 3370

Abstract

Introduction PF-06881894 is a proposed biosimilar to pegfilgrastim (Neulasta(R)). This study evaluated the pharmacodynamic/pharmacokinetic (PD/PK) equ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索